AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

NILOTINIB

20 registrations across 6 African markets— 16 active

Markets with NILOTINIB

Recent registrations

Brand / ProductMarketHolderStatusExpires
TASIGNA 200MG GELULE BOITE DE 28🇨🇮Côte d'IvoireNOVARTIS COTE D'IVOIRESASUexpiredAug 2022
TASIGNA 150MG GELULE BOITE DE 28🇨🇮Côte d'IvoireNOVARTIS COTE D'IVOIRESASUexpiredAug 2022
TASIGNA
Gélule / 150 mg
🇹🇳TunisiaNOVARTIS PHARMA SCHWEIZ AGexpiredFeb 2015
TASIGNA
Gélule / 200 mg
🇹🇳TunisiaNOVARTIS PHARMA SCHWEIZ AGexpiredFeb 2010
TASICAP 150🇿🇦South AfricaHetero Drugs South Africa (Pty) LtdactiveJan 1900
TILOMIA 200🇿🇦South AfricaHetero Drugs South Africa (Pty) LtdactiveJan 1900
TASILEUK 150🇿🇦South AfricaHetero Drugs South Africa (Pty) LtdactiveJan 1900
TASILEUK 200🇿🇦South AfricaHetero Drugs South Africa (Pty) LtdactiveJan 1900
TILOMIA 150🇿🇦South AfricaHetero Drugs South Africa (Pty) LtdactiveJan 1900
TASICAP 200🇿🇦South AfricaHetero Drugs South Africa (Pty) LtdactiveJan 1900
Tasigna
Capsules
🇹🇿TanzaniaNVS Kenya Limitedactive
Tasigna
Capsules, hard
🇹🇿TanzaniaNVS Kenya Limitedactive
Tasigna 150 mg
Capsule / 150 mg
🇸🇳SenegalNOVARTISactive
Tasigna 200 mg
Capsule / 200 mg
🇸🇳SenegalNOVARTISactive
Tasigna 150 mg
Capsule / 150 mg
🇸🇳SenegalNOVARTISactive
TASIGNA 200MG
CAPSULE
🇲🇦Moroccoactive
TASIGNA 200MG
CAPSULE
🇲🇦Moroccoactive
TASIGNA 200MG
CAPSULE
🇲🇦Moroccoactive
TASIGNA 200MG
CAPSULE
🇲🇦Moroccoactive
Tasigna 200 mg
Capsule / 200 mg
🇸🇳SenegalNOVARTISactive

NILOTINIB in Africa — Regulatory Overview

NILOTINIB is registered across 6 African markets with 20 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Morocco, Senegal, Côte d'Ivoire and 2 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 20 registrations, 16 (80%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.